An antibody fragment against human delta-like ligand-4 for inhibition of cell proliferation and neovascularization

Abstract

These data demonstrated the potential of Nanobody for application in targeting DLL4. Our findings may provide a basis for the development of novel therapeutic techniques to inhibit growth and neovascularization of tumors.